Insider Transactions in Q4 2024 at Tandem Diabetes Care Inc (TNDM)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2024
|
Rick Carpenter Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
145
-0.96%
|
$4,640
$32.66 P/Share
|
|
Dec 16
2024
|
Rick Carpenter Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
406
+2.62%
|
-
|
|
Dec 16
2024
|
Mark David Novara EVP & CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
10,732
-35.55%
|
$343,424
$32.66 P/Share
|
|
Dec 16
2024
|
Mark David Novara EVP & CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
29,658
+49.56%
|
-
|
|
Nov 21
2024
|
Kim D Blickenstaff Director |
SELL
Open market or private sale
|
Indirect |
30,000
-15.37%
|
$930,000
$31.38 P/Share
|
|
Nov 20
2024
|
Kim D Blickenstaff Director |
SELL
Open market or private sale
|
Indirect |
10,000
-4.87%
|
$300,000
$30.0 P/Share
|
|
Nov 15
2024
|
Elizabeth Anne Gasser EVP, Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
619
+17.16%
|
$9,285
$15.64 P/Share
|
|
Nov 15
2024
|
Elizabeth Anne Gasser EVP, Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,145
-13.82%
|
$30,915
$27.34 P/Share
|
|
Nov 15
2024
|
Elizabeth Anne Gasser EVP, Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,140
+18.74%
|
-
|
|
Nov 15
2024
|
John F Sheridan PRESIDENT & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
381
+0.7%
|
$5,715
$15.64 P/Share
|
|
Nov 15
2024
|
John F Sheridan PRESIDENT & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,309
-2.62%
|
$116,343
$27.34 P/Share
|
|
Nov 15
2024
|
John F Sheridan PRESIDENT & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,499
+4.81%
|
-
|
|
Nov 15
2024
|
Leigh Vosseller EVP & CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
765
-1.18%
|
$20,655
$27.34 P/Share
|
|
Nov 15
2024
|
Leigh Vosseller EVP & CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,140
+3.13%
|
-
|
|
Nov 15
2024
|
Shannon Marie Hansen EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
561
+4.65%
|
$8,415
$15.64 P/Share
|
|
Nov 15
2024
|
Shannon Marie Hansen EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
703
-3.17%
|
$18,981
$27.34 P/Share
|
|
Nov 15
2024
|
Shannon Marie Hansen EVP & Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,967
+8.04%
|
-
|
|
Nov 15
2024
|
Susan Morrison EVP & Chief Admin. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
613
-0.82%
|
$16,551
$27.34 P/Share
|
|
Nov 15
2024
|
Susan Morrison EVP & Chief Admin. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,140
+2.74%
|
-
|
|
Nov 15
2024
|
Rick Carpenter Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
563
+3.7%
|
$8,445
$15.64 P/Share
|
|
Nov 15
2024
|
Rick Carpenter Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
726
-2.55%
|
$19,602
$27.34 P/Share
|
|
Nov 15
2024
|
Rick Carpenter Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,033
+6.6%
|
-
|
|
Nov 15
2024
|
Mark David Novara EVP & CHIEF COMMERCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
532
+50.0%
|
$12,236
$23.24 P/Share
|